↓ Skip to main content

Stiripentol add-on therapy for drug-resistant focal epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, May 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)

Mentioned by

wikipedia
2 Wikipedia pages
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stiripentol add-on therapy for drug-resistant focal epilepsy
Published in
Cochrane database of systematic reviews, May 2020
DOI 10.1002/14651858.cd009887.pub5
Pubmed ID
Authors

Francesco Brigo, Stanley C Igwe, Nicola Luigi Bragazzi

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2020.
All research outputs
#4,854,460
of 15,482,859 outputs
Outputs from Cochrane database of systematic reviews
#7,634
of 11,201 outputs
Outputs of similar age
#73,073
of 191,192 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 11 outputs
Altmetric has tracked 15,482,859 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,201 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,192 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.